Exact Mass: 1068.4221

Exact Mass Matches: 1068.4221

Found 24 metabolites which its exact mass value is equals to given mass value 1068.4221, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Desmopressin

(2S)-2-({[(2S)-1-[(4R,7S,10S,13S,16S)-13-benzyl-6,9,12,15,18-pentahydroxy-10-[2-(C-hydroxycarbonimidoyl)ethyl]-7-[(C-hydroxycarbonimidoyl)methyl]-16-[(4-hydroxyphenyl)methyl]-1,2-dithia-5,8,11,14,17-pentaazacycloicosa-5,8,11,14,17-pentaene-4-carbonyl]pyrrolidin-2-yl](hydroxy)methylidene}amino)-5-carbamimidamido-N-[(C-hydroxycarbonimidoyl)methyl]pentanimidate

C46H64N14O12S2 (1068.4269)


Desmopressin is a chemical that is similar to Antidiuretic Hormone (ADH) which is found naturally in the body. It increases urine concentration and decreases urine production. Desmopressin is used to prevent and control excessive thirst, urination, and dehydration caused by injury, surgery, and certain medical conditions, allowing you to sleep through the night without awakening to urinate. It is also used to treat specific types of diabetes insipidus and conditions after head injury or pituitary surgery. H - Systemic hormonal preparations, excl. sex hormones and insulins > H01 - Pituitary and hypothalamic hormones and analogues > H01B - Posterior pituitary lobe hormones > H01BA - Vasopressin and analogues C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C80212 - Antidiuretic Hormone Analogue D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents > D014667 - Vasopressins D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D006401 - Hematologic Agents > D003029 - Coagulants > D006490 - Hemostatics D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D050034 - Antidiuretic Agents

   
   
   

landomycin U

landomycin U

C55H72O21 (1068.4566)


A natural product found in Streptomyces cyanogenus.

   
   

beta-D-glucopyranosyl-(1?3)-beta-D-glucopyranosyl-(1?3)-[6-O-(E)-p-methoxycinnamoyl]-beta-D-glucopyranosyl-(1?2)-[4-O-((E)-2-(4-acetamidobutylcarbamoyl)vinyl)-phenyl]-alpha-L-rhamnopyranoside|clerodendiod A

beta-D-glucopyranosyl-(1?3)-beta-D-glucopyranosyl-(1?3)-[6-O-(E)-p-methoxycinnamoyl]-beta-D-glucopyranosyl-(1?2)-[4-O-((E)-2-(4-acetamidobutylcarbamoyl)vinyl)-phenyl]-alpha-L-rhamnopyranoside|clerodendiod A

C49H68N2O24 (1068.4162)


   

(2S,4R)-1-[(3R,6S,9R,14R,17S,20S)-9-amino-17-(2-amino-2-oxoethyl)-3-benzyl-6-[(4-hydroxyphenyl)methyl]-2,5,8,16,19-pentaoxo-11,12-dithia-1,4,7,15,18-pentazabicyclo[18.3.0]tricosane-14-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneam

(2S,4R)-1-[(3R,6S,9R,14R,17S,20S)-9-amino-17-(2-amino-2-oxoethyl)-3-benzyl-6-[(4-hydroxyphenyl)methyl]-2,5,8,16,19-pentaoxo-11,12-dithia-1,4,7,15,18-pentazabicyclo[18.3.0]tricosane-14-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneam

C46H64N14O12S2 (1068.4269)


   

ALPHA-FUC-[1->2]-BETA-GAL-[1->3]-(ALPHA-FUC-[1->4])-BETA-GLCNAC-[1->3]-BETA-GAL-[1->4]-(ALPHA-FUC-[1->3])-BETA-GLCNAC-[1->3]-BETA-GAL-[1->4]-GLC

ALPHA-FUC-[1->2]-BETA-GAL-[1->3]-(ALPHA-FUC-[1->4])-BETA-GLCNAC-[1->3]-BETA-GAL-[1->4]-(ALPHA-FUC-[1->3])-BETA-GLCNAC-[1->3]-BETA-GAL-[1->4]-GLC

C42H72N2O29 (1068.4221)


   
   

Tenofovir Alafenamide Fumarate

Tenofovir Alafenamide Fumarate

C46H62N12O14P2 (1068.3983)


C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent

   
   

DESMOPRESSIN

(Deamino-Cys1,D-Arg8)-Vasopressin acetate salt

C46H64N14O12S2 (1068.4269)


H - Systemic hormonal preparations, excl. sex hormones and insulins > H01 - Pituitary and hypothalamic hormones and analogues > H01B - Posterior pituitary lobe hormones > H01BA - Vasopressin and analogues C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C80212 - Antidiuretic Hormone Analogue D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents > D014667 - Vasopressins D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D006401 - Hematologic Agents > D003029 - Coagulants > D006490 - Hemostatics D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D050034 - Antidiuretic Agents

   

(1s,2s,4s,5r,8r,9r,10s,13s,14r,17r,18r,20s)-10-{[(2r,3r,4s,5s,6r)-4-{[(2s,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-(sulfooxy)oxan-2-yl]oxy}-5-hydroxy-6-methyl-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-2-hydroxy-9,20-bis(hydroxymethyl)-4,5,9,13-tetramethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracos-15-ene-20-carboxylic acid

(1s,2s,4s,5r,8r,9r,10s,13s,14r,17r,18r,20s)-10-{[(2r,3r,4s,5s,6r)-4-{[(2s,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-(sulfooxy)oxan-2-yl]oxy}-5-hydroxy-6-methyl-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-2-hydroxy-9,20-bis(hydroxymethyl)-4,5,9,13-tetramethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracos-15-ene-20-carboxylic acid

C48H76O24S (1068.4447)


   

2-[({4,5-dihydroxy-3-[(1-hydroxy-2-{[(2e,4e)-1-hydroxy-4,6,14-trimethylhexadeca-2,4-dien-1-ylidene]amino}ethylidene)amino]-6-(hydroxymethyl)oxan-2-yl}oxy(hydroxy)phosphoryl)oxy]-4-[(2r,3s,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanoic acid

2-[({4,5-dihydroxy-3-[(1-hydroxy-2-{[(2e,4e)-1-hydroxy-4,6,14-trimethylhexadeca-2,4-dien-1-ylidene]amino}ethylidene)amino]-6-(hydroxymethyl)oxan-2-yl}oxy(hydroxy)phosphoryl)oxy]-4-[(2r,3s,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanoic acid

C45H73N4O23P (1068.4403)


   

n-{5-[(3-bromo-4-methoxyphenyl)methyl]-15-(3-carbamimidamidopropyl)-6,13,16,21-tetrahydroxy-8-isopropyl-4,11-dimethyl-3,9,22-trioxo-2-(sec-butyl)-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl}-2-[(1-hydroxybutylidene)amino]-4-methanesulfinylbutanimidic acid

n-{5-[(3-bromo-4-methoxyphenyl)methyl]-15-(3-carbamimidamidopropyl)-6,13,16,21-tetrahydroxy-8-isopropyl-4,11-dimethyl-3,9,22-trioxo-2-(sec-butyl)-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl}-2-[(1-hydroxybutylidene)amino]-4-methanesulfinylbutanimidic acid

C46H73BrN10O12S (1068.4313)


   

(1s,2s,4s,5r,8r,9r,10s,13s,14r,17s,18r,20s)-10-{[(2r,3r,4s,5s,6r)-4-{[(2s,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-(sulfooxy)oxan-2-yl]oxy}-5-hydroxy-6-methyl-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-2-hydroxy-9,20-bis(hydroxymethyl)-4,5,9,13-tetramethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracos-15-ene-20-carboxylic acid

(1s,2s,4s,5r,8r,9r,10s,13s,14r,17s,18r,20s)-10-{[(2r,3r,4s,5s,6r)-4-{[(2s,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-(sulfooxy)oxan-2-yl]oxy}-5-hydroxy-6-methyl-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-2-hydroxy-9,20-bis(hydroxymethyl)-4,5,9,13-tetramethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracos-15-ene-20-carboxylic acid

C48H76O24S (1068.4447)


   

1,11-dihydroxy-8-{[4-hydroxy-5-({5-hydroxy-4-[(5-{[4-hydroxy-5-({5-hydroxy-4-[(5-hydroxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-6-methyloxan-2-yl]oxy}-3-methyltetraphene-7,12-dione

1,11-dihydroxy-8-{[4-hydroxy-5-({5-hydroxy-4-[(5-{[4-hydroxy-5-({5-hydroxy-4-[(5-hydroxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-6-methyloxan-2-yl]oxy}-3-methyltetraphene-7,12-dione

C55H72O21 (1068.4566)


   

(2s)-n-[(2s,5s,8s,11r,12s,15s,18s,21r)-5-[(3-bromo-4-methoxyphenyl)methyl]-2-[(2s)-butan-2-yl]-15-(3-carbamimidamidopropyl)-6,13,16,21-tetrahydroxy-8-isopropyl-4,11-dimethyl-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2-[(1-hydroxybutylidene)amino]-4-[(r)-methanesulfinyl]butanimidic acid

(2s)-n-[(2s,5s,8s,11r,12s,15s,18s,21r)-5-[(3-bromo-4-methoxyphenyl)methyl]-2-[(2s)-butan-2-yl]-15-(3-carbamimidamidopropyl)-6,13,16,21-tetrahydroxy-8-isopropyl-4,11-dimethyl-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2-[(1-hydroxybutylidene)amino]-4-[(r)-methanesulfinyl]butanimidic acid

C46H73BrN10O12S (1068.4313)


   

6-{[(4z,6z,10z,14z,16z)-2-acetyl-17-[({5-[2-(3,5-dichloro-2-ethyl-4,6-dihydroxyphenyl)-1-hydroxy-2-oxoethyl]-4-hydroxy-3-methoxy-6-methyloxan-2-yl}oxy)methyl]-9-ethyl-12-hydroxy-5,7,11-trimethyl-18-oxo-1-oxacyclooctadeca-4,6,10,14,16-pentaen-8-yl]oxy}-4,5-dihydroxy-2,2-dimethyloxan-3-yl 2-methylpropanoate

6-{[(4z,6z,10z,14z,16z)-2-acetyl-17-[({5-[2-(3,5-dichloro-2-ethyl-4,6-dihydroxyphenyl)-1-hydroxy-2-oxoethyl]-4-hydroxy-3-methoxy-6-methyloxan-2-yl}oxy)methyl]-9-ethyl-12-hydroxy-5,7,11-trimethyl-18-oxo-1-oxacyclooctadeca-4,6,10,14,16-pentaen-8-yl]oxy}-4,5-dihydroxy-2,2-dimethyloxan-3-yl 2-methylpropanoate

C53H74Cl2O18 (1068.4252)


   

2-[({4,5-dihydroxy-3-[(1-hydroxy-2-{[(2e,4e)-1-hydroxy-4,6,14-trimethylhexadeca-2,4-dien-1-ylidene]amino}ethylidene)amino]-6-(hydroxymethyl)oxan-2-yl}oxy(hydroxy)phosphoryl)oxy]-4-[3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanoic acid

2-[({4,5-dihydroxy-3-[(1-hydroxy-2-{[(2e,4e)-1-hydroxy-4,6,14-trimethylhexadeca-2,4-dien-1-ylidene]amino}ethylidene)amino]-6-(hydroxymethyl)oxan-2-yl}oxy(hydroxy)phosphoryl)oxy]-4-[3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanoic acid

C45H73N4O23P (1068.4403)


   

(1s,2s,4s,5r,8r,9r,10s,13s,14r,18r,20s)-10-{[(2r,3r,4s,5s,6r)-4-{[(2s,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-(sulfooxy)oxan-2-yl]oxy}-5-hydroxy-6-methyl-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-2-hydroxy-9,20-bis(hydroxymethyl)-4,5,9,13-tetramethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracos-15-ene-20-carboxylic acid

(1s,2s,4s,5r,8r,9r,10s,13s,14r,18r,20s)-10-{[(2r,3r,4s,5s,6r)-4-{[(2s,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-(sulfooxy)oxan-2-yl]oxy}-5-hydroxy-6-methyl-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-2-hydroxy-9,20-bis(hydroxymethyl)-4,5,9,13-tetramethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracos-15-ene-20-carboxylic acid

C48H76O24S (1068.4447)


   

2-({[4,5-dihydroxy-3-({1-hydroxy-2-[(1-hydroxy-4,6,14-trimethylhexadeca-2,4-dien-1-ylidene)amino]ethylidene}amino)-6-(hydroxymethyl)oxan-2-yl]oxy(hydroxy)phosphoryl}oxy)-4-[3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanoic acid

2-({[4,5-dihydroxy-3-({1-hydroxy-2-[(1-hydroxy-4,6,14-trimethylhexadeca-2,4-dien-1-ylidene)amino]ethylidene}amino)-6-(hydroxymethyl)oxan-2-yl]oxy(hydroxy)phosphoryl}oxy)-4-[3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanoic acid

C45H73N4O23P (1068.4403)


   

6-({2-acetyl-17-[({5-[2-(3,5-dichloro-2-ethyl-4,6-dihydroxyphenyl)-1-hydroxy-2-oxoethyl]-4-hydroxy-3-methoxy-6-methyloxan-2-yl}oxy)methyl]-9-ethyl-12-hydroxy-5,7,11-trimethyl-18-oxo-1-oxacyclooctadeca-4,6,10,14,16-pentaen-8-yl}oxy)-4,5-dihydroxy-2,2-dimethyloxan-3-yl 2-methylpropanoate

6-({2-acetyl-17-[({5-[2-(3,5-dichloro-2-ethyl-4,6-dihydroxyphenyl)-1-hydroxy-2-oxoethyl]-4-hydroxy-3-methoxy-6-methyloxan-2-yl}oxy)methyl]-9-ethyl-12-hydroxy-5,7,11-trimethyl-18-oxo-1-oxacyclooctadeca-4,6,10,14,16-pentaen-8-yl}oxy)-4,5-dihydroxy-2,2-dimethyloxan-3-yl 2-methylpropanoate

C53H74Cl2O18 (1068.4252)


   

(2s)-n-[(2s,5s,8s,11r,12s,15s,18s,21r)-5-[(3-bromo-4-methoxyphenyl)methyl]-2-[(2s)-butan-2-yl]-15-(3-carbamimidamidopropyl)-6,13,16,21-tetrahydroxy-8-isopropyl-4,11-dimethyl-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2-[(1-hydroxybutylidene)amino]-4-methanesulfinylbutanimidic acid

(2s)-n-[(2s,5s,8s,11r,12s,15s,18s,21r)-5-[(3-bromo-4-methoxyphenyl)methyl]-2-[(2s)-butan-2-yl]-15-(3-carbamimidamidopropyl)-6,13,16,21-tetrahydroxy-8-isopropyl-4,11-dimethyl-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2-[(1-hydroxybutylidene)amino]-4-methanesulfinylbutanimidic acid

C46H73BrN10O12S (1068.4313)